NO992091L - Farmas°ytiske blandinger inneholdende lamivudin og zidovudin - Google Patents

Farmas°ytiske blandinger inneholdende lamivudin og zidovudin

Info

Publication number: NO992091L
Authority: NO; Norway
Prior art keywords: zidovudine; preparations containing; surface preparations; containing lamivudine; pharmaceutical surface
Prior art date: 1996-10-31

Application number

NO992091A

Other languages

English (en)

Other versions

NO317163B1 (no

NO992091D0 (no

Inventor

Gary Wayne Goodson

Allen Wayne Wood

Katherine Jeannette Ford

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-31

Filing date

1999-04-29

Publication date

1999-06-29

1999-04-29 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1999-04-29 Publication of NO992091D0 publication Critical patent/NO992091D0/no

1999-06-29 Publication of NO992091L publication Critical patent/NO992091L/no

2004-08-30 Publication of NO317163B1 publication Critical patent/NO317163B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

NO19992091A 1996-10-31 1999-04-29 Farmasoytiske blandinger inneholdende lamivudin og zidovudin NO317163B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9622681.6A GB9622681D0 (en)	1996-10-31	1996-10-31	Pharmaceutical compositions
PCT/EP1997/005953 WO1998018477A2 (en)	1996-10-31	1997-10-29	Pharmaceutical compositions containing lamivudine and zidovudine

Publications (3)

Publication Number	Publication Date
NO992091D0 NO992091D0 (no)	1999-04-29
NO992091L true NO992091L (no)	1999-06-29
NO317163B1 NO317163B1 (no)	2004-08-30

Family

ID=10802224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19992091A NO317163B1 (no)	1996-10-31	1999-04-29	Farmasoytiske blandinger inneholdende lamivudin og zidovudin

Country Status (44)

Country	Link
EP (1)	EP0941100B1 (no)
JP (1)	JP2001502718A (no)
KR (1)	KR100551652B1 (no)
AP (1)	AP1067A (no)
AR (1)	AR009135A1 (no)
AT (1)	ATE241364T1 (no)
AU (1)	AU736607B2 (no)
BG (1)	BG64541B1 (no)
BR (1)	BR9712614A (no)
CA (1)	CA2270174A1 (no)
CO (1)	CO4930269A1 (no)
CY (1)	CY2485B1 (no)
CZ (1)	CZ296080B6 (no)
DE (1)	DE69722433T2 (no)
DK (1)	DK0941100T3 (no)
EA (1)	EA002437B1 (no)
EE (1)	EE03806B1 (no)
ES (1)	ES2200204T3 (no)
GB (1)	GB9622681D0 (no)
GE (1)	GEP20022735B (no)
GT (1)	GT199700116A (no)
HK (1)	HK1020880A1 (no)
HR (1)	HRP970569B1 (no)
HU (1)	HU224969B1 (no)
ID (1)	ID18698A (no)
IL (1)	IL129422A0 (no)
IS (1)	IS5024A (no)
MY (1)	MY119513A (no)
NO (1)	NO317163B1 (no)
NZ (1)	NZ335153A (no)
OA (1)	OA11038A (no)
PA (1)	PA8441101A1 (no)
PE (1)	PE10099A1 (no)
PL (1)	PL190349B1 (no)
PT (1)	PT941100E (no)
SI (1)	SI0941100T1 (no)
SK (1)	SK284286B6 (no)
SV (1)	SV1997000090A (no)
TR (1)	TR199900950T2 (no)
UA (1)	UA64725C2 (no)
UY (1)	UY24766A1 (no)
WO (1)	WO1998018477A2 (no)
YU (1)	YU19999A (no)
ZA (1)	ZA979726B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
CZ20041117A3 (cs) *	2002-04-23	2005-04-13	Lupin Limited	Dlouhodobě působící kompozice zahrnující zidovudin a lamivudin
ES2286471T3 (es) *	2002-11-08	2007-12-01	Glaxo Group Limited	Composiciones farmaceuticas antivirales.
ATE398455T1 (de)	2003-01-14	2008-07-15	Gilead Sciences Inc	Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
AR045841A1 (es) *	2004-09-28	2005-11-16	Richmond Sa Com Ind Y Financie	Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r, 8r, 10r,11r)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
EP2579892A2 (en)	2010-06-09	2013-04-17	Vaccine Technologies, Incorporated	Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment
AU2013229274A1 (en)	2012-03-05	2014-09-04	Cipla Limited	Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
US20140234415A1 (en) *	2013-02-20	2014-08-21	Abbvie Inc.	Tablet Dosage Forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4950652A (en) *	1987-03-23	1990-08-21	Hem Research, Inc.	dsRNAs for combination therapy in the treatment of viral diseases
DE19875016I2 (de) *	1991-05-16	2004-07-01	Glaxo Group Ltd	Nukleosidanalogen enthaltende Antiviren-Zubereitungen.
GB9110624D0 (en) *	1991-05-16	1991-07-03	Glaxo Group Ltd	Combinations
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions

1996
- 1996-10-31 GB GBGB9622681.6A patent/GB9622681D0/en active Pending
1997
- 1997-10-24 HR HR970569A patent/HRP970569B1/xx not_active IP Right Cessation
- 1997-10-28 SV SV1997000090A patent/SV1997000090A/es not_active Application Discontinuation
- 1997-10-28 CO CO97063174A patent/CO4930269A1/es unknown
- 1997-10-28 MY MYPI97005103A patent/MY119513A/en unknown
- 1997-10-29 IL IL12942297A patent/IL129422A0/xx not_active IP Right Cessation
- 1997-10-29 AR ARP970105027A patent/AR009135A1/es unknown
- 1997-10-29 KR KR1019997003757A patent/KR100551652B1/ko not_active IP Right Cessation
- 1997-10-29 NZ NZ335153A patent/NZ335153A/en unknown
- 1997-10-29 PE PE1997000965A patent/PE10099A1/es not_active Application Discontinuation
- 1997-10-29 WO PCT/EP1997/005953 patent/WO1998018477A2/en active IP Right Grant
- 1997-10-29 PT PT97950036T patent/PT941100E/pt unknown
- 1997-10-29 ES ES97950036T patent/ES2200204T3/es not_active Expired - Lifetime
- 1997-10-29 SI SI9730570T patent/SI0941100T1/xx unknown
- 1997-10-29 UA UA99042239A patent/UA64725C2/uk unknown
- 1997-10-29 AP APAP/P/1999/001519A patent/AP1067A/en active
- 1997-10-29 PL PL97333143A patent/PL190349B1/pl unknown
- 1997-10-29 BR BR9712614-4A patent/BR9712614A/pt not_active IP Right Cessation
- 1997-10-29 EP EP97950036A patent/EP0941100B1/en not_active Expired - Lifetime
- 1997-10-29 EE EEP199900175A patent/EE03806B1/xx not_active IP Right Cessation
- 1997-10-29 EA EA199900345A patent/EA002437B1/ru not_active IP Right Cessation
- 1997-10-29 YU YU19999A patent/YU19999A/sh unknown
- 1997-10-29 DE DE69722433T patent/DE69722433T2/de not_active Expired - Lifetime
- 1997-10-29 SK SK575-99A patent/SK284286B6/sk unknown
- 1997-10-29 AU AU53142/98A patent/AU736607B2/en not_active Ceased
- 1997-10-29 AT AT97950036T patent/ATE241364T1/de active
- 1997-10-29 CA CA002270174A patent/CA2270174A1/en not_active Abandoned
- 1997-10-29 GT GT199700116A patent/GT199700116A/es unknown
- 1997-10-29 HU HU0000344A patent/HU224969B1/hu not_active IP Right Cessation
- 1997-10-29 DK DK97950036T patent/DK0941100T3/da active
- 1997-10-29 TR TR1999/00950T patent/TR199900950T2/xx unknown
- 1997-10-29 ZA ZA979726A patent/ZA979726B/xx unknown
- 1997-10-29 GE GEAP19974781A patent/GEP20022735B/en unknown
- 1997-10-29 JP JP10520045A patent/JP2001502718A/ja active Pending
- 1997-10-29 CZ CZ0155799A patent/CZ296080B6/cs not_active IP Right Cessation
- 1997-10-30 PA PA19978441101A patent/PA8441101A1/es unknown
- 1997-10-30 UY UY24766A patent/UY24766A1/es not_active IP Right Cessation
- 1997-10-30 ID IDP973554A patent/ID18698A/id unknown
1999
- 1999-04-09 IS IS5024A patent/IS5024A/is unknown
- 1999-04-23 OA OA9900088A patent/OA11038A/en unknown
- 1999-04-29 NO NO19992091A patent/NO317163B1/no unknown
- 1999-05-26 BG BG103435A patent/BG64541B1/bg unknown
- 1999-12-24 HK HK99106129A patent/HK1020880A1/xx not_active IP Right Cessation
2004
- 2004-11-26 CY CY0400085A patent/CY2485B1/xx unknown

Also Published As

Publication number	Publication date
HRP970569A2 (en)	1998-08-31
SI0941100T1 (en)	2003-12-31
KR100551652B1 (ko)	2006-02-13
DE69722433T2 (de)	2004-04-08
UA64725C2 (uk)	2004-03-15
AR009135A1 (es)	2000-03-08
WO1998018477A3 (en)	1998-06-18
EE03806B1 (et)	2002-08-15
PL190349B1 (pl)	2005-11-30
IS5024A (is)	1999-04-09
SK57599A3 (en)	2000-06-12
SK284286B6 (sk)	2005-01-03
BG103435A (en)	2000-04-28
NZ335153A (en)	2001-04-27
PA8441101A1 (es)	2000-05-24
MY119513A (en)	2005-06-30
ATE241364T1 (de)	2003-06-15
PE10099A1 (es)	1999-03-02
AU736607B2 (en)	2001-08-02
CO4930269A1 (es)	2000-06-27
WO1998018477A2 (en)	1998-05-07
ZA979726B (en)	1999-04-29
AP9901519A0 (en)	1999-06-30
PT941100E (pt)	2003-10-31
EA002437B1 (ru)	2002-04-25
GT199700116A (es)	1999-04-22
ES2200204T3 (es)	2004-03-01
SV1997000090A (es)	1998-10-07
HU224969B1 (en)	2006-04-28
TR199900950T2 (xx)	1999-07-21
BR9712614A (pt)	1999-10-26
CZ296080B6 (cs)	2006-01-11
EP0941100B1 (en)	2003-05-28
EA199900345A1 (ru)	2000-02-28
IL129422A0 (en)	2000-02-17
BG64541B1 (bg)	2005-07-29
DE69722433D1 (de)	2003-07-03
YU19999A (sh)	2000-10-30
AU5314298A (en)	1998-05-22
NO317163B1 (no)	2004-08-30
NO992091D0 (no)	1999-04-29
CA2270174A1 (en)	1998-05-07
HUP0000344A3 (en)	2002-04-29
OA11038A (en)	2002-02-06
KR20000052893A (ko)	2000-08-25
EP0941100A2 (en)	1999-09-15
CZ155799A3 (cs)	1999-10-13
HRP970569B1 (en)	2004-10-31
EE9900175A (et)	1999-12-15
UY24766A1 (es)	2000-12-29
HK1020880A1 (en)	2000-05-26
CY2485B1 (en)	2005-06-03
HUP0000344A2 (hu)	2001-05-28
GB9622681D0 (en)	1997-01-08
GEP20022735B (en)	2002-07-25
DK0941100T3 (da)	2003-09-01
JP2001502718A (ja)	2001-02-27
PL333143A1 (en)	1999-11-22
ID18698A (id)	1998-04-30
AP1067A (en)	2002-05-01

Publication	Publication Date	Title
NO20002359L (no)	2000-07-05	Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
BR9607317A (pt)	1997-12-30	Peptídios e composição farmacêutica
BR9607318A (pt)	1997-12-30	Peptidos e composição farmacêutica
IS4496A (is)	1997-06-04	Úðablöndur úr peptíðum og próteinum
NO943511D0 (no)	1994-09-21	Farmasöytiske preparater og anvendelse derav
FI973244L (fi)	1998-04-08	Farmaseuttisia valmisteita nenänsisäiseen käyttöön
NO20000700L (no)	2000-04-14	Interleukin-18-proteiner samt fremstilling og anvendelse derav
DE69800639D1 (de)	2001-05-03	Tetrahydrolipstatin enthaltende präparate
DE69625368D1 (de)	2003-01-23	Schweisshemmende deodorierende präparaten
NO985539D0 (no)	1998-11-27	Farmas°ytiske blandinger
NO994009D0 (no)	1999-08-19	Gensekvensator og metoder
DK0799577T3 (da)	2001-06-18	Peptidblanding og produkter deraf
PL334976A1 (en)	2000-03-27	Pharmaceutic preparations containing amoxycyclin and clavulate
NO994438D0 (no)	1999-09-13	Terapeutisk aktive diarylpropylaminer samt fremstilling og anvendelse derav
DK0804078T3 (da)	2000-04-10	Sammensætning og anvendelse deraf
NO995324L (no)	1999-12-28	Baerer for gjenstander og emne for denne
DK0991666T3 (da)	2008-04-14	Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO963344D0 (no)	1996-08-09	Peptider gjenkjent ved melanoma-spesifikke cytotoksiske lymfocytter og anvendelse derav
DE59707298D1 (de)	2002-06-20	Desodorierende zubereitungen
NO965023D0 (no)	1996-11-26	Maltitolblanding og fremstilling derav
NO992091D0 (no)	1999-04-29	Farmas°ytiske blandinger inneholdende lamivudin og zidovudin
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
FI963334L (fi)	1996-08-27	Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
DK0826679T3 (da)	2002-05-21	Naphthylforbindelser og -præparater
DK1005342T3 (da)	2003-03-24	Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid